Institutions profited after Brii Biosciences Limiteds market cap rose HK109m last week but individual investors profited the most - Simply Wall St
BRIBF Stock | USD 0.13 0.00 0.00% |
Roughly 56% of Brii Biosciences' investor base is looking to short. The analysis of overall sentiment of trading Brii Biosciences Limited pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Brii Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Brii Biosciences stock news signals to limit their universe of possible portfolio assets.
Brii Biosciences pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Brii daily returns and investor perception about the current price of Brii Biosciences Limited as well as its diversification or hedging effects on your existing portfolios.
Brii |
Institutions profited after Brii Biosciences Limiteds market cap rose HK109m last week but individual investors profited the most Simply Wall St
Read at news.google.com
Brii Biosciences Fundamental Analysis
We analyze Brii Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Brii Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Brii Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Earnings Per Share
Earnings Per Share Comparative Analysis
Brii Biosciences is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Brii Biosciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Brii Biosciences pink sheet to make a market-neutral strategy. Peer analysis of Brii Biosciences could also be used in its relative valuation, which is a method of valuing Brii Biosciences by comparing valuation metrics with similar companies.
Peers
Brii Biosciences Related Equities
ZVSA | ZyVersa Therapeutics | 7.86 | ||||
ACAD | ACADIA Pharmaceuticals | 7.13 | ||||
XFOR | X4 Pharmaceuticals | 6.12 | ||||
ETNB | 89bio | 2.52 | ||||
HOOK | Hookipa Pharma | 2.51 | ||||
AXSM | Axsome Therapeutics | 1.58 | ||||
INZY | Inozyme Pharma | 1.54 | ||||
DAWN | Day One | 1.05 | ||||
BNTC | Benitec Biopharma | 0.28 | ||||
INCY | Incyte | 0.17 | ||||
SRPT | Sarepta Therapeutics | 0.60 | ||||
TERN | Terns Pharmaceuticals | 0.64 | ||||
ALZN | Alzamend Neuro | 0.84 | ||||
AKRO | Akero Therapeutics | 2.27 | ||||
CABA | Cabaletta Bio | 2.31 | ||||
MIRM | Mirum Pharmaceuticals | 2.63 | ||||
VRAX | Virax Biolabs | 3.27 | ||||
AVTX | Avalo Therapeutics | 4.49 | ||||
SONN | Sonnet Biotherapeutics | 14.50 | ||||
CDIO | Cardio Diagnostics | 20.63 |
Complementary Tools for Brii Pink Sheet analysis
When running Brii Biosciences' price analysis, check to measure Brii Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brii Biosciences is operating at the current time. Most of Brii Biosciences' value examination focuses on studying past and present price action to predict the probability of Brii Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brii Biosciences' price. Additionally, you may evaluate how the addition of Brii Biosciences to your portfolios can decrease your overall portfolio volatility.
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Transaction History View history of all your transactions and understand their impact on performance | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |